Christina Schwarz’s practice focuses on complex patent litigation under the Hatch-Waxman Act and contested proceedings before the United States Patent Office, including inter partes review proceedings and patent interference proceedings. She has experience counseling clients, providing opinions, and working on cases involving a range of pharmaceutical and biotechnology products, including drugs or treatments for immunosuppression, renal disease, HCV, Pompe disease, schizophrenia, modified dosage forms, drug delivery devices and polymers.
In 2007, Christina served as a law clerk to the Honourable Justice Roger T. Hughes of the Federal Court of Canada.
Idenix Pharmaceuticals, Inc., et al. v. Gilead Pharmasset LLC
Christina helped obtain judgment in favor of client Gilead in a patent interference against Idenix relating to nucleoside analogs useful for treating HCV infection.